Previous 10 | Next 10 |
Gainers: Enservco (ENSV) +36%. Camber Energy (CEI) +20%. Marine Petroleum Trust (MARPS) +15%. Independence Contract Drilling (ICD) +13%. Houston American Energy (HUSA) +11%. Losers: Cypress Environmental Partners (CELP) -41%. Hycroft Mining Holding (HYMC) -9%. IAMGOLD (IAG) -8%. Zym...
Gainers: MedAvail Holdings (MDVL) +51%. Borqs Technologies (BRQS) +27%. Verastem (VSTM) +26%. Lexaria Bioscience (LEXX) +22%. Splash Beverage Group (SBEV) +18%. HighPeak Energy (HPK) +17%. Cardiol Therapeutics (CRDL) +16%. Airgain (AIRG) +15%. CoreCivic (CXW) +14%. Renren (RENN) +13%. Losers:...
EMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the first quarter 2022 after market close on Thursday, May 12, 2022. The company’s managemen...
Gainers: Origin Agritech (SEED) +16%. Intrepid Potash (IPI) +12%. Sigma Lithium (SGML) +10%. LSB Industries (LXU) +10%. Uranium Energy (UEC) +10%. Losers: Advent Technologies Holdings (ADN) -9%. Zymergen (ZY) -9%. Houston American Energy (HUSA) -9%. Cadiz (CDZI) -9%. Frontline (FRO)...
Zymergen (ZY -5.3%) stock has plunged after two brokerages lowered price target on the biotechnology firm. UBS Group cut its price target on the stock, from $13.00 to $4.00 while maintaining a "Neutral" rating. The Goldman Sachs also maintained its "Neutral" rating on Zymergen, but lowered th...
Image source: The Motley Fool. Zymergen Inc. (NASDAQ: ZY) Q4 2021 Earnings Call Mar 22, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Zymergen Inc. (ZY) Q4 2021 Earnings Call Transcript
Zymergen, Inc. (ZY) Q4 2021 Earnings Conference Call March 22, 2022, 16:30 ET Company Participants Mike Dulin - Director, Communications Jay Flatley - Chairman & Acting CEO Enakshi Singh - CFO Conference Call Participants Poon Mah - Cowen and Company Michael Ryskin - Bank of America Merri...
Zymergen press release (NASDAQ:ZY): Q4 GAAP EPS of -$0.76 beats by $0.09. Revenue of $3.04M (-48.6% Y/Y) misses by $0.3M. Shares +1.67%. For further details see: Zymergen GAAP EPS of -$0.76 beats by $0.09, revenue of $3.04M misses by $0.3M
EMERYVILLE, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the fourth quarter and full year ended December 31, 2021. “Our strategy is c...
ADBE, AIR, APTO, AVGR, CLBS, GAN, HQY, OTCQB:NEXCF, PAGS, PAYS, POSH, SLDP, WOR, ZY For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Tuesday's close
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Completes Acquisition of Zymergen PR Newswire BOSTON and EMERYVILLE, Calif. , Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced t...